BAYER SCHERING PHARMA AG v. Sandoz, Inc.
District Court, S.D. New York
1Opinion of the Court
MEMORANDUM OPINION & ORDER
PAUL G. GARDEPHE, District Judge.
These actions arise from Defendants’ filing of Abbreviated New Drug Applications concerning two of Plaintiffs’ brand-name oral contraceptive prescription drugs: Yasmin and Yaz. As a result of two prior decisions 1 and certain stipulations between the parties, 2 only Defendant Sandoz, Inc.’s Sherman Act counterclaims remain to be decided.
In a March 29, 2010 Memorandum Opinion and Order, this Court dismissed San-doz’s Sherman Act counterclaims but granted leave to amend. Bayer Schera Pharma AG v. Sandoz, Inc., Nos. 08 Civ. 03710(PGG),…
2Cases cited33 opinions
- Ashcroft v. IqbalSupreme Court of the United States · 2009
- Bell Atlantic Corp. v. TwomblySupreme Court of the United States · 2007
- Swierkiewicz v. Sorema N. A.Supreme Court of the United States · 2002
- Chambers v. Time Warner, Inc.Court of Appeals for the Second Circuit · 2002
- United States v. Grinnell Corp.Supreme Court of the United States · 1966
28 more not listed; retrieve them via the Exa API.
3Cited by18 opinions
- Concord Associates, L.P. v. Entertainment Properties TrustCourt of Appeals for the Second Circuit · 2016
- In re Crude Oil Commodity Futures LitigationDistrict Court, S.D. New York · 2012
- Shak v. JPMorgan Chase & Co.District Court, S.D. New York · 2016
- A.V.E.L.A., Inc. v. Estate of Marilyn Monroe, LLCDistrict Court, S.D. New York · 2017
- United Food & Commercial Workers Local 1776 & Participating Emp'rs Health & Welfare Fund v. Teikoku Pharma United StatesDistrict Court, N.D. California · 2017
13 more not listed; retrieve them via the Exa API.